[Event Report] HGPI Special Seminar “How can patients and the public participate meaningfully in health policymaking?” (May 23, 2023)
date : 7/28/2023
This special HGPI seminar was hosted by Health and Global Policy Institute and The Health Policy Partnership, a UK-based health policy think-tank.
Citizen participation in healthcare policymaking can increase trust among patients and the public, help build capacity among the people participating and improve the quality and appropriateness of decision-making. As citizen involvement in policymaking is becoming more common, we need to ensure this participation is genuine and valued as much as other kinds of evidence.
The webinar provided an opportunity to learn about what is needed to ensure patients and the public can feed into policy design in a meaningful way. Patient advocates and experts in policy discussed the importance of involving patients and the public in health policymaking, lessons learnt from successful engagement in Japan and Europe, and the opportunities for participatory policy development offered by the digitisation of healthcare.
We were joined by patient advocates and policy experts, Shinsuke Amano (Group Nexus Japan), Penilla Gunther (FOKUS Patient) and Ryoji Noritake (HGPI). The webinar featured live two-way translation between Japanese and English.
The recording is available at the HPP website for English, and here for Japanese version.
*Due to technical reasons, there may be some unclear or hard-to-understand parts in the video and audio. We appreciate your understanding in this matter.
[Overview]
- Speakers:
Jody Tate (Director of Research, The Health Policy Partnership)
Penilla Gunther (Founder/Program Director, FOKUS Patient)
Ryoji Noritake (CEO/Board Member, HGPI)
Shinsuke Amano (Executive Director, Japan Federation of Cancer Patient Groups/Executive Director, Group Nexus Japan)
- Date & Time: Tuesday, May 23, 2023; 18:00-18:45 JST
- Format: Online (Zoom Webinar)
- Languages: English and Japanese (with simultaneous interpretation)
- Participation fee: Free
- Hosted by: Health and Global Policy Institute (HGPI)/ The Health Policy Partnership
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-24
[Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)



